Physician

Shruti B. Sanghvi, M.D.

According to 2025 Medicare claims, Shruti Sanghvi, M.D. (NPI: 1518073220) practices rheumatology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is SOUTHWEST SPINE AND PAIN CARE SPECIALISTS, LLC (NPI: 1144509985; TIN: 27-3995478) and primary practice location at 84117-7168.

Sanghvi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 171 traditional Medicare patients, billed 92,413 HCPCS/CPT codes, and received $931,164 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 426 prescription claims across 173 beneficiaries totaling $121,359 in drug costs, led by Hydroxychloroquine Sulfate (Hydroxychloroquine Sulfate). 2018 DME data shows 12 claims. Open Payments data shows 134 records totaling $1,818. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $748,047 and ending at $931,164. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	221	26,907	$748,047
2016	237	34,280	$763,467
2017	226	39,105	$829,536
2018	227	59,485	$1,217,814
2019	222	73,815	$1,246,446
2020	220	77,588	$1,392,018
2021	211	76,778	$1,320,151
2022	137	60,793	$643,056
2023	149	104,623	$979,420
2024	171	92,413	$931,164

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	284	2,546	$974,472
2016	303	2,620	$1,033,407
2017	313	2,767	$1,087,638
2018	325	2,774	$1,145,479
2019	323	2,733	$1,202,161
2020	334	2,965	$1,690,030
2021	333	2,901	$1,567,081
2022	281	1,831	$949,146
2023	244	1,581	$840,666
2024	173	426	$121,359

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$1,449
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	52	62	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	512	$90
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	54	310	$44
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	101	211	$12
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	76	448	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	80	6,477	$3,682
Methotrexate	Methotrexate Sodium	97	7,955	$2,609
Sulfasalazine	Sulfasalazine	13	1,085	$544
Prednisone	Prednisone	62	2,851	$429
Folic Acid	Folic Acid	35	3,099	$281

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	134	$1,818	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shruti B. Sanghvi, M.D.?

Tedicare shows public-source Medicare data for Shruti B. Sanghvi, M.D. (NPI 1518073220), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shruti B. Sanghvi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shruti B. Sanghvi, M.D.?

Shruti B. Sanghvi, M.D. is linked to SOUTHWEST SPINE AND PAIN CARE SPECIALISTS, LLC (billing NPI 1144509985) in the available physician profile data.

Does Shruti B. Sanghvi, M.D. have Open Payments data?

Shruti B. Sanghvi, M.D. has 134 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.